Mereo BioPharma Group Plc (MREO)

0.3429 +0.01 (+1.60%) USD  |  NASDAQ  |  Sep 25, 14:51
More

Mereo BioPharma Group Cash from Operations (TTM) : -25.28M for June 30, 2026

Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 -25.28M
March 31, 2026 -26.99M
December 31, 2025 -31.04M
September 30, 2025 -32.70M
Date Value
June 30, 2025 -33.07M
March 31, 2025 -33.22M
December 31, 2024 -32.85M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -9.219M
NuCana Plc -6.332M
BioNTech SE 725.62M
Silence Therapeutics Plc -41.79M
Compass Pathways Plc -160.76M